| 000 | 01726 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513183104.0 | ||
| 264 | 0 | _c19990723 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a1040-9238 | ||
| 024 | 7 |
_a10.1080/10409239991209246 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrye, L L | |
| 245 | 0 | 0 |
_aLanosterol analogs: dual-action inhibitors of cholesterol biosynthesis. _h[electronic resource] |
| 260 |
_bCritical reviews in biochemistry and molecular biology _c1999 |
||
| 300 |
_a123-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCoronary Disease _xmetabolism |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xphysiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl CoA Reductases _xphysiology |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aKetones _xchemistry |
| 650 | 0 | 4 |
_aLanosterol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aOxidoreductases _xphysiology |
| 650 | 0 | 4 |
_aOximes _xchemistry |
| 650 | 0 | 4 | _aRNA Processing, Post-Transcriptional |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 | _aSterol 14-Demethylase |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLeonard, D A | |
| 773 | 0 |
_tCritical reviews in biochemistry and molecular biology _gvol. 34 _gno. 2 _gp. 123-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10409239991209246 _zAvailable from publisher's website |
| 999 |
_c10292211 _d10292211 |
||